LISA GRUBBS: Open Payments
NPI 1215435912 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 24 payments from 9 companies in 2025. Trend: 2023 $182 · 2024 $299 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $153 |
| Novo Nordisk Inc | 4 | $99 |
| Tonix Medicines, Inc. | 1 | $84 |
| Lilly USA, LLC | 3 | $80 |
| PFIZER INC. | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| RGH Enterprises LLC | 1 | $26 |
| Lucid Diagnostics Inc. | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, VOQUEZNA, LEQVIO, PAXLOVID, PREVNAR 20, FARXIGA.
Industry payments across MA — which companies pay providers there.
